Article info

Original research
ZEB1 transcription factor promotes immune escape in melanoma

Authors

  • Maud Plaschka Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Valentin Benboubker Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Maxime Grimont Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Justine Berthet Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles
  • Laurie Tonon Fondation Synergie Lyon Cancer, Plateforme de bio-informatique Gilles Thomas, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Jonathan Lopez Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Myrtille Le-Bouar Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles
  • Brigitte Balme Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles
  • Garance Tondeur Dermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles
  • Arnaud de la Fouchardière Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Lionel Larue Institut Curie, PSL Research University, Paris, France PubMed articlesGoogle scholar articles
  • Alain Puisieux Institut Curie, PSL Research University, Paris, France PubMed articlesGoogle scholar articles
  • Yenkel Grinberg-Bleyer Molecular Regulation of Immunity in Cancer, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  • Nathalie Bendriss-Vermare Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles
  • Bertrand Dubois Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles
  • Christophe Caux Cancer Immune Surveillance and Therapeutic Targeting, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceLaboratory of Immunotherapy of Cancer of Lyon (LICL), Lyon, France PubMed articlesGoogle scholar articles
  • Stéphane Dalle Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, FranceDermatology Unit, Hospices Civils de Lyon, CH Lyon Sud, Pierre Bénite, France PubMed articlesGoogle scholar articles
  • Julie Caramel Cancer Cell Plasticity in Melanoma, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon, INSERM 1052, CNRS 5286, Centre Léon Bérard, Lyon, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Julie Caramel; julie.caramel{at}lyon.unicancer.fr
View Full Text

Citation

Plaschka M, Benboubker V, Grimont M, et al
ZEB1 transcription factor promotes immune escape in melanoma

Publication history

  • Accepted January 31, 2022
  • First published March 14, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.